Results 101 to 110 of about 5,855,669 (305)

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

open access: yesMolecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen   +19 more
wiley   +1 more source

Diagnosis, staging and treatment of patients with gestational trophoblastic disease

open access: yes, 2015
This guideline is intended for all health professionals involved in the diagnosis, staging and treatment of patients with GTD, such as gynaecologists, radiologists, pathologists, surgeons, medical oncologists, GPs and nursing staff.
National Clinical Effectiveness Committee (NCEC)
core  

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Unexpected Intraoperative Life Threatening Haemorrhage: National Clinical Guideline No. 29: Annex A: Clinical Guidelines for the Management of Massive Haemorrhage – A systematic review. [PDF]

open access: yes, 2020
In 2016, the Department of Health requested that the Health Research Board (HRB) fund an evidence synthesis service called HRB-CICER (Collaboration in Ireland for Clinical Effectiveness Reviews) to support the activities of the Ministerial appointed ...
National Clinical Effectiveness Committee (NCEC)   +2 more
core  

Ion therapy guideline (Version 2020)

open access: yesPrecision Radiation Oncology, 2021
Qiuning Zhang   +3 more
doaj   +1 more source

Informed Consent for Spine Procedures: Best Practice Guideline from the American Society of Pain and Neuroscience (ASPN)

open access: yesJournal of Pain Research, 2023
Timothy Deer,1 Ankur A Patel,2 Dawood Sayed,3 Ashley Bailey-Classen,4 Ashley Comer,1 Benjamin Gill,5 Kiran Patel,6 Alaa Abd-Elsayed,7 Natalie Strand,8 Jonathan M Hagedorn,9 Zohra Hussaini,3 Nasir Khatri,10 Ryan Budwany,1 Melissa Murphy,11 Dan Nguyen,12 ...
Deer T   +22 more
doaj  

Reply to “Clinical practice guidelines or clinical research guidelines?” [PDF]

open access: yesClinical Neurophysiology, 2018
Baillet, Sylvain   +14 more
openaire   +2 more sources

Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells

open access: yesMolecular Oncology, EarlyView.
We established the avian chorioallantoic membrane (CAM) assay as a scalable in vivo model for studying circulating tumor cells (CTCs). Human gastrointestinal tumors spontaneously released genetically validated CTCs that were detected across multiple platforms, demonstrating that the CAM model provides an accessible tool for investigating early cancer ...
Dennis Roth   +17 more
wiley   +1 more source

Clinical Practice Guidelines of Chinese Medicine Rehabilitation for Ischemic Stroke (Cerebral Infarction)Working Group of Clinical Practice Guidelines of Chinese Medicine Rehabilitation for Ischemic Stroke (Cerebral Infarction)

open access: yes康复学报, 2021
Ischemic stroke (cerebral infarction) is a common clinical disease of ischemic necrosis or softening of localized brain tissue, which belongs to "stroke disease" in traditional Chinese medicine (TCM).
Working Group of Clinical Practice Guidelines of Chinese Medicine Rehabilitation for Ischemic Stroke (Cerebral Infarction)
doaj  

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy